Construction and in vitro properties of chimeric simian and human immunodeficiency virus with the human TNF-alpha gene

Microbiology and Immunology

Volumn 46, Issue 12, 2002, Pages 849-855

  Haga, Takeshi ^a   Shimizu, Yuya ^a   Okoba, Masashi ^a   Kumabe, Shino ^a   Goto, Yoshitaka ^a   Shinjo, Toshiharu ^a   Ichimura, Hiroshi ^b   Kuwata, Takeo ^c   Hayami, Masanori ^c   Miura, Tomoyuki ^c  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

AIDS; Monkey; SHIV; TNF alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHIMERA; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; MONKEY; MONONUCLEAR CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036908414     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2002.tb02772.x     Document Type: Article

References (35)

1. Aukrust, P., Liabakk, N.B., Muller, F., Lien, E., Espevik, T., and Froland, S.S. 1994. Serum levels of tumor necrosis factor-alpha (TNF alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection - Correlations to clinical, immunologic, and virologic parameters. J. Infect. Dis. 169: 420-424.
2. Badley, A.D., Dockrell, D., Simpson, M., Schut, R., Lynch, D.H., Leibson, P., and Paya, C.V. 1997. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185: 55-64.
3. Clapham, P.R., Weiss, R.A., Dalgleish, A.G., Exley, M., Whitby, D., and Hogg, N. 1987. Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: Receptor modulation and differentiation induced by phorbol ester. Virology 158: 44-51.
4. Clerici, M., and Shearer, G.M. 1993. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14: 107-111.
5. Estaquier, J., Idziorek, T., de Bels, F., Barre-Sinoussi, F., Hurtrel, B., Aubertin, A.M., Venet, A., Mehtali, M., Muchmore, E., Michel, P., et al. 1994. Programmed cell death and AIDS: Significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc. Natl. Acad. Sci. U.S.A. 91: 9431-9435.
6. Folks, T.M., Clouse, K.A., Justement, J., Rabson, A., Duh, E., Kehrl, J.H., and Fauci, A.S. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. U.S.A. 86: 2365-2368.
7. Giavedoni, L.D., and Yilma, T. 1996. Construction and characterization of replication-competent simian immunodeficiency virus vectors that express gamma interferon. J. Virol. 70: 2247-2251.
8. Graziosi, C., Gantt, K.R., Vaccarezza, M., Demarest, J.F., Daucher, M., Saag, M.S., Shaw, G.M., Quinn, T.C., Cohen, O.J., Welbon, C.C., Pantaleo, G., and Fauci, A.S. 1996. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. Proc. Natl. Acad. Sci. U.S.A. 93: 4386-4391.
9. Gundlach, B.R., Linhart, H., Dittmer, U., Sopper, S., Reiprich, S., Fuchs, D., Fleckenstein, B., Hunsmann, G., Stahl-Hennig, C., and Uberla, K. 1997. Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2. J. Virol. 71: 2225-2232.
10. Haga, T., Kuwata, T., Kozyrev, I., Kwofie, T.B., Hayami, M., and Miura, T. 2000. Construction of an SIV/HIV type 1 chimeric virus with the human interleukin 6 gene and its production of interleukin 6 in monkey and human cells. AIDS Res. Hum. Retroviruses 16: 577-582.
11. Haga, T., Kuwata, T., Ui, M., Igarashi, T., Miyazaki, Y., and Hayami, M. 1998. A new approach to AIDS research and prevention: The use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines. Microbiol. Immunol. 42: 245-251.
12. Hayami, M., Igarashi, T., Kuwata, T., Ui, M., Haga, T., Ami, Y., Shinohara, K., and Honda, M. 1999. Gene-mutated HIV-1/SIV chimeric viruses as AIDS live attenuated vaccines for potential human use. Leukemia 13 (Suppl. 1): S42-47.
13. Hirano, K., Yamamoto, K., Kobayashi, Y., and Osawa, T. 1989. Characterization of specific high-affinity receptor for human lymphotoxin. J. Biochem. (Tokyo) 105: 120-126.
14. Hornung, F., Scala, G., and Lenardo, M.J. 2000. TNF-alpha-induced secretion of C-C chemokines modulates C-C chemokine receptor 5 expression on peripheral blood lymphocytes. J. Immunol. 164: 6180-6187.
15. Igarashi, T., Shibata, R., Hasebe, F., Ami, Y., Shinohara, K., Komatsu, T., Stahl-Hennig, C., Petry, H., Hunsmann, G., Kuwata, T., et al. 1994. Persistent infection with SIVmac chimeric virus having tat, rev, vpu, env and nef of HIV type 1 in macaque monkeys. AIDS Res. Hum. Retroviruses 10: 1021-1029.
16. Klein, S.A., Dobmeyer, J.M., Dobmeyer, T.S., Falke, D., Kabelitz, D., Friese, K., Helm, E.B., Hoelzer, D., and Rossol-Voth, R. 1996. TNF-alpha mediated apoptosis of CD4 positive T-lymphocytes. A model of T-cell depletion in HIV infected individuals. Eur. J. Med. Res. 1: 249-258.
17. Kozak, M. 1983. Comparison of initiation of protein synthesis in procaryotes, eucaryotes, and organelles. Microbiol. Rev. 47: 1-45.
18. Kozak, M. 1986. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44: 283-292.
19. Kozyrev, I.L., Miura, T., Haga, T., Kuwata, T., and Hayami, M. 2001. Construction of SIV/HIV-1 chimeric viruses having the IL-5 gene and determination of their ability to replicate and produce IL-5. Arch. Virol. 146: 1051-1062.
20. Kozyrev, I.L., Miura, T., Takemura, T., Kuwata, T., Ui, M., Ibuki, K., Iida, T., and Hayami, M. 2002. Co-expression of interleukin-5 influences replication of simian/human immunodeficiency viruses in vivo. J. Gen. Virol. 83: 1183-1188.
21. Kuwata, T., Igarashi, T., Ido, E., Jin, M., Mizuno, A., Chen, J., and Hayami, M. 1995. Construction of human immunodeficiency virus 1/simian immunodeficiency virus strain mac chimeric viruses having vpr and/or nef of different parental origins and their in vitro and in vivo replication. J. Gen. Virol. 76: 2181-2191.
22. Kuwata, T., Miura, T., Haga, T., Kozyrev, I., and Hayami, M. 2000. Construction of chimeric simian and human immunodeficiency viruses that produce interleukin 12. AIDS Res. Hum. Retroviruses 16: 465-470.
23. Lahdevirta, J., Maury, C.P., Teppo, A.M., and Repo, H. 1988. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85: 289-291.
24. Lane, B.R., Markovitz, D.M., Woodford, N.L., Rochford, R., Strieter, R.M., and Coffey, M.J. 1999. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J. Immunol. 163: 3653-3661.
25. Meyaard, L., Otto, S.A., Jonker, R.R., Mijnster, M.J., Keet, R.P., and Miedema, F. 1992. Programmed death of T cells in HIV-1 infection. Science 257: 217-219.
26. Nabel, G., and Baltimore, D. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713.
27. Navikas, V., Link, J., Persson, C., Olsson, T., Hojeberg, B., Ljungdahl, A., Link, H., and Wahren, B. 1995. Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9: 484-489.
28. Quinto, I., Mallardo, M., Baldassarre, F., Scala, G., Englund, G., and Jeang, K.T. 1999. Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development. J. Biol. Chem. 274: 17567-17572.
29. Reed, L.J., and Muench, H. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27: 493-497.
30. Robert-Guroff, M., Popovic, M., Gartner, S., Markham, P., Gallo, R.C., and Reitz, M.S. 1990. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Virol. 64: 3391-3398.
31. Shibata, R., Kawamura, M., Sakai, H., Hayami, M., Ishimoto, A., and Adachi, A. 1991. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J. Virol. 65: 3514-3520.
32. Shirai, T., Yamaguchi, H., Ito, H., Todd, C.W., and Wallace, R.B. 1985. Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature 313: 803-806.
33. Takai, T., and Ohmori, H. 1990. DNA transfection of mouse lymphoid cells by the combination of DEAE-dextran-mediated DNA uptake and osmotic shock procedure. Biochim. Biophys. Acta 1048: 105-109.
34. Willey, R.L., Smith, D.H., Lasky, L.A., Theodore, T.S., Earl, P.L., Moss, B., Capon, D.J., and Martin, M.A. 1988. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62: 139-147.
35. Zheng, L., Fisher, G., Miller, R.E., Peschon, J., Lynch, D.H. and Lenardo, M.J. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348-351.